hexamethylene bisacetamide has been researched along with ATLL in 4 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cecchinato, V | 1 |
| Erba, E | 1 |
| Basile, A | 1 |
| Scarpati, B | 1 |
| Fazi, C | 1 |
| Brando, B | 1 |
| Comi, P | 1 |
| Chiaramonte, R | 1 |
| Buonamici, S | 1 |
| Aifantis, I | 1 |
| Brody, JP | 1 |
| Allen, S | 1 |
| Schulman, P | 1 |
| Sun, T | 1 |
| Chan, WC | 1 |
| Friedman, HD | 1 |
| Teichberg, S | 1 |
| Koduru, P | 1 |
| Cone, RW | 1 |
| Loughran, TP | 1 |
| Ruefli, AA | 1 |
| Smyth, MJ | 1 |
| Johnstone, RW | 1 |
4 other studies available for hexamethylene bisacetamide and ATLL
| Article | Year |
|---|---|
Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
Topics: Acetamides; Antineoplastic Agents; Cell Line, Tumor; Cyclin-Dependent Kinase 4; gamma-Aminobutyric A | 2008 |
Hexamethylene bisacetamide as a treatment for T-cell leukemia (T-ALL).
Topics: Acetamides; Antineoplastic Agents; Humans; Leukemia-Lymphoma, Adult T-Cell | 2008 |
Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents.
Topics: Acetamides; Butyrates; Butyric Acid; Chromosome Aberrations; Chromosome Disorders; DNA, Neoplasm; DN | 1995 |
HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance.
Topics: Acetamides; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 9; Caspases; | 2000 |